Global Liquid Biopsy Market, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments

Description

List of Tables

The global liquid biopsy market is predicted to reach US$ 13.72 Billion by 2031, from US$ 3.94 Billion in 2023. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel market growth over the forecast period.

The liquid biopsy market is a rapidly growing sector with numerous companies focusing on scientific advancements. For instance, in November 2023, Illumina Inc. announced TruSight Oncology 500 ctDNA v2, an advanced iteration of its liquid biopsy assay designed for comprehensive genomic profiling in oncology. This upgraded version promises enhanced sensitivity and specificity in detecting cancer-associated mutations from circulating tumor DNA. Further, in November 2023, Foundation Medicine, Inc., and Pierre Fabre Laboratories announced a collaboration to develop Foundation Medicine's high-quality genomic tests, FoundationOne CDx and FoundationOne Liquid CDx, as companion diagnostics for new targeted therapies to treat patients with non-small cell lung cancer (NSCLC).

Recent Developments

In January 2024, Guardant Health, Inc. and Hikma Pharmaceuticals PLC, announced an agreement to promote Guardant Health's portfolio of liquid and tissue biopsy tests for cancer screening, recurrence monitoring and tumor mutation profiling across all solid cancers in countries across the Middle East and North Africa (MENA).
In November 2023, Foundation Medicine, Inc., and Pierre Fabre Laboratories announced a collaboration to develop Foundation Medicine's high-quality genomic tests, FoundationOne CDx and FoundationOne Liquid CDx, as companion diagnostics for new targeted therapies to treat patients with non-small cell lung cancer (NSCLC).
In July 2023, MiRXES raised US$ 50 Million in series D venture funding for the development and commercialization of liquid biopsy products targeting colorectal cancer and the multi-cancer early detection test.
In May 2023, Labcorp, a leading global life sciences company, launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for patients with advanced or metastatic solid tumors.

By Circulating Biomarker: Global Liquid Biopsy Market and Forecast - Key Takeaways

Based on circulating biomarkers, the circulating tumor cells (CTCs) segment dominated the global liquid biopsy market in 2023.
The circulating tumor DNA (ctDNA) is the second largest segment of the liquid biopsy market capturing over a quarter share in 2023.
The extracellular vesicles (EVs) is expected to be the fastest-growing segment in the circulating biomarkers market over the forecast period.

By Products: Global Liquid Biopsy Market and Forecast - Key Takeaways

Based on product, the Kits and Consumables segment accounted for largest share of the liquid biopsy market in 2023.
The instruments segment is likely to witness fastest growth in the global liquid biopsy market over the forecast period.
The services segment captured least share of the global liquid biopsy market.

By Application: Global Liquid Biopsy Market and Forecast - Key Takeaways

The global liquid biopsy market, by application, is being dominated by oncology segment. Lung cancer and breast cancer accounted for largest share of the liquid biopsy oncology market. Together, they controlled approx. 42% share of the liquid biopsy oncology market in 2023.
The non-cancer application is expected to be the fastest-growing segment in the market over the forecast period. Among non-cancer application, Non-invasive prenatal testing (NIPT) dominated the market.

By Clinical Application: Global Liquid Biopsy Oncology Market and Forecast - Key Takeaways

Based on clinical application, the therapy selection segment dominated the global liquid biopsy market in 2023, and is expected to lead the market over the forecast period.
Treatment monitoring captured second highest share of the liquid biopsy market in 2023, followed by the early cancer screening application.
Recurrence monitoring captured least share of the liquid biopsy market.

By End User: Global Liquid Biopsy Market and Forecast - Key Takeaways

Reference laboratories form the largest and fastest-growing end-user segment of the liquid biopsy market.
Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2023, followed by Academic and Research Centers.

By Sample Type: Global Liquid Biopsy Market and Forecast - Key Takeaways

Blood is the most widely used sample type and is expected to remain the largest market over the forecast period as well.
The urine sample segment is anticipated to witness noticeable growth over the forecast period.

By Region: Global Liquid Biopsy Market and Forecast - Key Takeaways

North America accounted for largest share of the global liquid biopsy market in 2023, followed by the Europe.
In Europe, Germany and France are the leading market for liquid biopsy.
Asia Pacific is the fastest growing market for liquid biopsy. In Asia Pacific, Japan and China are the leading market for liquid biopsy. China represents a huge opportunity for liquid biopsy market because of increased market access of country's population to healthcare resources.
South America and Middle East & Africa are competing closely to grab maximum share of the global liquid biopsy market.

iGATE RESEARCH, report titled "Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Non-Cancer Application, Sample Type, Region & Country Analysis), Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031" provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.

This 607 Pages report with 130 Figures and 9 Tables has been analyzed from 16 viewpoints:

1. Global Liquid Biopsy Market & Forecast (2018 - 2031)

2. Global Liquid Biopsy Market Share & Forecast (2018 - 2031)

3. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2018 - 2031)

4. Global Liquid Biopsy Market & Forecast - by Product (2018 - 2031)

5. Global Liquid Biopsy Market & Forecast - by Application (2018 - 2031)

6. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2018 - 2031)

7. Global Liquid Biopsy Non-Cancer Application Market & Forecast - By Types (2018 - 2031)

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2018 - 2031)

9. Global Liquid Biopsy Market & Forecast - by End User (2018 - 2031)

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2018 - 2031)

11. Liquid Biopsy Market & Forecast - Regional Analysis (2018 - 2031)

12. Liquid Biopsy Market Share & Forecast - Country Analysis (2018 - 2031)

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. 35 Company Profiles - Recent Developments / Initiatives, Major Deals

16. Global Liquid Biopsy Market - Driving Factors & Challenges

By Circulating Biomarker: Global Liquid Biopsy Market and Forecast

1. Circulating Tumor Cells (CTCs)

2. Circulating Tumor DNA (ctDNA)

3. Cell-Free DNA (cfDNA)

4. Extracellular Vesicles (EVs)

5. Other Circulating Biomarkers

By Product: Global Liquid Biopsy Market and Forecast

1. Kits and Consumables

2. Instruments

3. Services

By Application: Global Liquid Biopsy Market and Forecast

1. Oncology Application

Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Gastrointestinal Cancer
Leukaemia
Others

2. Non-Cancer Application

Non-Invasive Prenatal Testing (NIPT)
Organ Transplantation
Infectious Disease Testing

By Clinical Application: Global Liquid Biopsy Market and Forecast

1. Therapy Selection

2. Treatment Monitoring

3. Early Cancer Screening

4. Recurrence Monitoring

By End User: Global Liquid Biopsy Market and Forecast

1. Reference Laboratories

2. Hospitals and Physician Laboratories

3. Academic and Research Centers

4. Other End Users

By Sample Type: Global Liquid Biopsy Market and Forecast

1. Blood Sample

2. Urine Sample

3. Other Fluids Sample

By Region: Global Liquid Biopsy Market and Forecast

1. North America

United States
Canada
Mexico

2. Asia Pacific

South Korea
Japan
China
India
Australia
Rest of Asia Pacific

3. Europe

Germany
France
United Kingdom
Italy
Spain
Rest of Europe

4. Middle East & Africa

UAE
Saudi Arabia
Egypt
Rest of Middle East & Africa

5. South America

Brazil
Argentina
Rest of South America

Global Liquid Biopsy Market - Company Profiles, Recent Developments, Major Deals

1. Personal Genome Diagnostics (Acquired by Labcorp)

2. Guardant Health, Inc.

3. Pathway Genomics (Now OME CARE)

4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

5. Cardiff Oncology (Previously Trovagene, Inc.)

6. LungLife AI (Formerly Cynvenio Biosystems, Inc.)

7. Biocept, Inc.

8. ANGLE plc

9. MDxHealth

10. Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)

11. Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)

12. Foundation Medicine, Inc

13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

14. Genomic Health (Now Part of Exact Sciences Corp)

15. Myriad Genetics, Inc

16. Thermo Fisher Scientific, Inc

17. QIAGEN NV

18. Bio-Rad Laboratories, Inc

19. Menarini-Silicon Biosystems

20. GRAIL

21. NeoGenomics, Inc.

22. DiaCarta, Inc.

23. OncoCell MDx (Now Immunis.AI)

24. C2i Genomics (Acquired by Veracyte, Inc.)

25. Biodesix

26. Freenome

27. Inivata

28. CellMax Life

29. Rarecyte Inc.

30. Saga Diagnostics

31. Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)

32. Lucence Diagnostics Pte Ltd

33. Karius, Inc.

34. Clinical Genomics Technologies Pty Ltd (CG)

35. Elypta

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

1. Executive Summary

2. Global Liquid Biopsy Market & Forecast (2018 - 2031)

3. Global Liquid Biopsy Market Share & Forecast (2018 - 2031)

3.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
3.2 Global Liquid Biopsy Market Share & Forecast - by Product
3.3 Global Liquid Biopsy Market Share & Forecast - by Application
3.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
3.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
3.6 Global Liquid Biopsy Non-Cancer Application Market Share & Forecast - By Types
3.7 Global Liquid Biopsy Market Share & Forecast - by End User
3.8 Global Liquid Biopsy Market Share & Forecast - by Sample Type
3.9 Liquid Biopsy Market Share & Forecast - Regional Analysis
3.10 Liquid Biopsy Market Share & Forecast - Country Analysis

4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2018 - 2031)

4.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
4.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
4.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
4.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
4.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

5. Global Liquid Biopsy Market & Forecast - by Product (2018 - 2031)

5.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
5.2 Global Liquid Biopsy - Instruments Market & Forecast
5.3 Global Liquid Biopsy - Services Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Application (2018 - 2031)

6.1 Global Liquid Biopsy - Oncology Application Market & Forecast
6.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
- 6.2.1 Lung Cancer Liquid Biopsy Market & Forecast
- 6.2.2 Breast Cancer Liquid Biopsy Market & Forecast
- 6.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
- 6.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
- 6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
- 6.2.6 Leukaemia Liquid Biopsy Market & Forecast
- 6.2.7 Others Liquid Biopsy Market & Forecast
6.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast
6.4 Global Liquid Biopsy Non-Cancer Application Market & Forecast - By Types
- 6.4.1 Non-Invasive Prenatal Testing (NIPT) Liquid Biopsy Market & Forecast
- 6.4.2 Organ Transplantation Liquid Biopsy Market & Forecast
- 6.4.3 Infectious Disease Testing Liquid Biopsy Market & Forecast

7. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2018 - 2031)

7.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
7.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
7.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
7.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

8. Global Liquid Biopsy Market & Forecast - by End User (2018 - 2031)

8.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
8.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
8.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
8.4 Global Liquid Biopsy - Other End Users Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by Sample Type (2018 - 2031)

9.1 Global Liquid Biopsy - Blood Sample Market & Forecast
9.2 Global Liquid Biopsy - Urine Sample Market & Forecast
9.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

10. Liquid Biopsy Market & Forecast - Regional Analysis (2018 - 2031)

10.1 North America Liquid Biopsy Market & Forecast
10.2 Asia Pacific Liquid Biopsy Market & Forecast
10.3 Europe Liquid Biopsy Market & Forecast
10.4 South America Liquid Biopsy Market & Forecast
10.5 Middle East & Africa Liquid Biopsy Market & Forecast

11. Liquid Biopsy Market & Forecast - Country Analysis (2018 - 2031)

11.1 North America Liquid Biopsy Market & Forecast
- 11.1.1 United States Liquid Biopsy Market & Forecast
- 11.1.2 Canada Liquid Biopsy Market & Forecast
- 11.1.3 Mexico Liquid Biopsy Market & Forecast
11.2 Asia Pacific Liquid Biopsy Market & Forecast
- 11.2.1 South Korea Liquid Biopsy Market & Forecast
- 11.2.2 Japan Liquid Biopsy Market & Forecast
- 11.2.3 China Liquid Biopsy Market & Forecast
- 11.2.4 India Liquid Biopsy Market & Forecast
- 11.2.5 Australia Liquid Biopsy Market & Forecast
- 11.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
11.3 Europe Liquid Biopsy Market & Forecast
- 11.3.1 Germany Liquid Biopsy Market & Forecast
- 11.3.2 France Liquid Biopsy Market & Forecast
- 11.3.3 United Kingdom Liquid Biopsy Market & Forecast
- 11.3.4 Italy Liquid Biopsy Market & Forecast
- 11.3.5 Spain Liquid Biopsy Market & Forecast
- 11.3.6 Rest of Europe Liquid Biopsy Market & Forecast
11.4 Middle East & Africa Liquid Biopsy Market & Forecast
- 11.4.1 UAE Liquid Biopsy Market & Forecast
- 11.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
- 11.4.3 Egypt Liquid Biopsy Market & Forecast
- 11.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
11.5 South America Liquid Biopsy Market & Forecast
- 11.5.1 Brazil Liquid Biopsy Market & Forecast
- 11.5.2 Argentina Liquid Biopsy Market & Forecast
- 11.5.3 Rest of South America Liquid Biopsy Market & Forecast

12. Liquid Biopsy Initiatives

13. Liquid Biopsy Companies Financing Details

14. Company Profiles

14.1 Personal Genome Diagnostics (Acquired by Labcorp)
- 14.1.1 Company Overview
- 14.1.2 Recent Developments / Initiatives
14.2 Guardant Health, Inc.
- 14.2.1 Company Overview
- 14.2.2 Recent Developments / Initiatives
14.3 Pathway Genomics (Now OME CARE)
- 14.3.1 Company Overview
- 14.3.2 Recent Developments / Initiatives
14.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
- 14.4.1 Company Overview
- 14.4.2 Recent Developments / Initiatives
14.5 Cardiff Oncology (Previously Trovagene, Inc.)
- 14.5.1 Company Overview
- 14.5.2 Recent Developments / Initiatives
14.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.)
- 14.6.1 Company Overview
- 14.6.2 Recent Developments / Initiatives
14.7 Biocept, Inc.
- 14.7.1 Company Overview
- 14.7.2 Recent Developments / Initiatives
14.8 ANGLE plc
- 14.8.1 Company Overview
- 14.8.2 Recent Developments / Initiatives
14.9 MDxHealth
- 14.9.1 Company Overview
- 14.9.2 Recent Developments / Initiatives
14.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
- 14.10.1 Company Overview
- 14.10.2 Recent Developments / Initiatives
14.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
- 14.11.1 Company Overview
- 14.11.2 Recent Developments / Initiatives
14.12 Foundation Medicine, Inc.
- 14.12.1 Company Overview
- 14.12.2 Recent Developments / Initiatives
14.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
- 14.13.1 Company Overview
- 14.13.2 Recent Developments / Initiatives
14.14 Genomic Health (Now Part of Exact Sciences Corp)
- 14.14.1 Company Overview
- 14.14.2 Recent Developments / Initiatives
14.15 Myriad Genetics, Inc.
- 14.15.1 Company Overview
- 14.15.2 Recent Developments / Initiatives
14.16 Thermo Fisher Scientific, Inc.
- 14.16.1 Company Overview
- 14.16.2 Recent Developments / Initiatives
14.17 QIAGEN NV
- 14.17.1 Company Overview
- 14.17.2 Recent Developments / Initiatives
14.18 Bio-Rad Laboratories, Inc.
- 14.18.1 Company Overview
- 14.18.2 Recent Developments / Initiatives
14.19 Menarini-Silicon Biosystems
- 14.19.1 Company Overview
- 14.19.2 Recent Developments / Initiatives
14.20 GRAIL
- 14.20.1 Company Overview
- 14.20.2 Recent Developments / Initiatives
14.21 NeoGenomics, Inc.
- 14.21.1 Company Overview
- 14.21.2 Recent Developments / Initiatives
14.22 DiaCarta, Inc.
- 14.22.1 Company Overview
- 14.22.2 Recent Developments / Initiatives
14.23 OncoCell MDx (Now Immunis.AI)
- 14.23.1 Company Overview
- 14.23.2 Recent Developments / Initiatives
14.24 C2i Genomics (Acquired by Veracyte, Inc.)
- 14.24.1 Company Overview
- 14.24.2 Recent Developments / Initiatives
14.25 Biodesix
- 14.25.1 Company Overview
- 14.25.2 Recent Developments / Initiatives
14.26 Freenome
- 14.26.1 Company Overview
- 14.26.2 Recent Developments / Initiatives
14.27 Inivata
- 14.27.1 Company Overview
- 14.27.2 Recent Developments / Initiatives
14.28 CellMax Life
- 14.28.1 Company Overview
- 14.28.2 Recent Developments / Initiatives
14.29 RareCyte Inc.
- 14.29.1 Company Overview
- 14.29.2 Recent Developments / Initiatives
14.30 Saga Diagnostics
- 14.30.1 Company Overview
- 14.30.2 Recent Developments / Initiatives
14.31 Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)
- 14.31.1 Company Overview
- 14.31.2 Recent Developments / Initiatives
14.32 Lucence Diagnostics Pte Ltd
- 14.32.1 Company Overview
- 14.32.2 Recent Developments / Initiatives
14.33 Karius, Inc.
- 14.33.1 Company Overview
- 14.33.2 Recent Developments / Initiatives
14.34 Clinical Genomics Technologies Pty Ltd (CG)
- 14.34.1 Company Overview
- 14.34.2 Recent Developments / Initiatives
14.35 Elypta
- 14.35.1 Company Overview
- 14.35.2 Recent Developments / Initiatives

15. Global Liquid Biopsy Market - Driving Factors

16. Global Liquid Biopsy Market - Challenges

List of Figures:

Figure 2-1: Global - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 2-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 3-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2018 - 2023
Figure 3-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Figure 3-3: By Product - Liquid Biopsy Market Share (Percent), 2018 - 2023
Figure 3-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Figure 3-5: By Application - Liquid Biopsy Market Share (Percent), 2018 - 2023
Figure 3-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Figure 3-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2018 - 2023
Figure 3-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2024 - 2031
Figure 3-9: By End User - Liquid Biopsy Market Share (Percent), 2018 - 2023
Figure 3-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Figure 3-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2018 - 2023
Figure 3-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Figure 4-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2018 - 2023
Figure 4-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2024 - 2031
Figure 4-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2018 - 2023
Figure 4-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2024 - 2031
Figure 4-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2018 - 2023
Figure 4-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2024 - 2031
Figure 4-7: Global Liquid Biopsy - Extracellular Vesicles (EVs) Market (Million US$), 2018 - 2023
Figure 4-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (EVs) Market (Million US$), 2024 - 2031
Figure 4-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2018 - 2023
Figure 4-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2024 - 2031
Figure 5-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2018 - 2023
Figure 5-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2024 - 2031
Figure 5-3: Global Liquid Biopsy - Instruments Market (Million US$), 2018 - 2023
Figure 5-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2024 - 2031
Figure 5-5: Global Liquid Biopsy - Services Market (Million US$), 2018 - 2023
Figure 5-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2024 - 2031
Figure 6-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2018 - 2023
Figure 6-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2024 - 2031
Figure 6-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-15: Global - Others Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 6-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 6-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2018 - 2023
Figure 6-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2024 - 2031
Figure 6-19: Global Liquid Biopsy - NIPT Market (Million US$), 2018 - 2023
Figure 6-20: Global Liquid Biopsy - Forecast for NIPT Market (Million US$), 2024 - 2031
Figure 6-21: Global Liquid Biopsy - Organ Transplantation Market (Million US$), 2018 - 2023
Figure 6-22: Global Liquid Biopsy - Forecast for Organ Transplantation Market (Million US$), 2024 - 2031
Figure 6-23: Global Liquid Biopsy - Infectious Disease Testing Market (Million US$), 2018 - 2023
Figure 6-24: Global Liquid Biopsy - Forecast for Infectious Disease Testing Market (Million US$), 2024 - 2031
Figure 7-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2018 - 2023
Figure 7-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2024 - 2031
Figure 7-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2018 - 2023
Figure 7-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2024 - 2031
Figure 7-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2018 - 2023
Figure 7-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2024 - 2031
Figure 7-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2018 - 2023
Figure 7-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2024 - 2031
Figure 8-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2018 - 2023
Figure 8-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2024 - 2031
Figure 8-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2018 - 2023
Figure 8-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2024 - 2031
Figure 8-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2018 - 2023
Figure 8-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2024 - 2031
Figure 8-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2018 - 2023
Figure 8-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2024 - 2031
Figure 9-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2018 - 2023
Figure 9-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2024 - 2031
Figure 9-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2018 - 2023
Figure 9-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2024 - 2031
Figure 9-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2018 - 2023
Figure 9-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2024 - 2031
Figure 10-1: North America - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 10-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 10-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 10-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 10-5: Europe - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 10-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 10-7: South America - Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 10-8: South America - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 10-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 10-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-1: United States - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-3: Canada - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-5: Mexico - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-6: Mexico - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-7: South Korea - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-8: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-9: Japan - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-10: Japan - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-11: China - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-12: China - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-13: India - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-14: India - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-15: Australia - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-16: Australia - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-17: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-18: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-19: Germany - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-20: Germany - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-21: France - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-22: France - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-23: United Kingdom - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-24: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-25: Italy - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-26: Italy - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-27: Spain - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-28: Spain - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-29: Rest of Europe - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-30: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-31: UAE - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-32: UAE - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-33: Saudi Arabia - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-34: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-35: Egypt - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-36: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-37: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-38: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-39: Brazil - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-40: Brazil - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-41: Argentina - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-42: Argentina - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031
Figure 11-43: Rest of South America - Liquid Biopsy Market (Million US$), 2018 - 2023
Figure 11-44: Rest of South America - Forecast for Liquid Biopsy Market (Million US$), 2024 - 2031

List of Tables:

Table 3-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2018 - 2023
Table 3-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2024 - 2031
Table 3-3: By Types - Liquid Biopsy Non-Cancer Application Market Share (Percent), 2018 - 2023
Table 3-4: By Types - Forecast for Liquid Biopsy Non-Cancer Application Market Share (Percent), 2024 - 2031
Table 3-5: By Region - Liquid Biopsy Market Share (Percent), 2018 - 2023
Table 3-6: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Table 3-7: By Country - Liquid Biopsy Market Share (Percent), 2018 - 2023
Table 3-8: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2024 - 2031
Table 14-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions

Global Liquid Biopsy Market, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031